Concepedia

Process Development For Conjugates

Process Development for Conjugates is a methodological framework within biotherapeutic manufacturing that specifically systematizes the design, optimization, and scalable production of antibody-drug conjugates by integrating controlled conjugation chemistry, analytical characterization, and process robustness to ensure consistent product quality and efficacy.

32

Publications

1K

Citations

183

Authors

57

Institutions

Publications per year

2017–2026

13

Parents

Publications

32

The fabrication of novel zein and resveratrol covalent conjugates: Enhanced thermal stability, emulsifying and antioxidant properties

Gerui Ren, Jieyu Shi, Sijie Huang et al. · Food Chemistry · 2021 · 99 citations

, , +17

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Peter L. Turecek, M.J. Bossard, Michael Graninger et al. · PubMed · 2012 · 96 citations

, , +13

A novel method to prepare protein-polysaccharide conjugates with high grafting and low browning: Application in encapsulating curcumin

Wanying He, Liang Tian, Shanshan Zhang et al. · LWT · 2021 · 84 citations

, , +14

Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones

Calise Bahou, Daniel A. Richards, Antoine Maruani et al. · Organic & Biomolecular Chemistry · 2018 · 81 citations · Full text

, , +17

Review: Poly(Ethylene Glycol)s with Reactive Endgroups. II. Practical Consideration for the Preparation of Protein-PEG Conjugates

Gert Hooftman, S Overkleeft Herman, Etienne Schacht · Journal of Bioactive and Compatible Polymers · 1996 · 59 citations

, , +17

1–5 of 32

Authors

183

  1. PL
    Peter L. Turecek

    Baxter (Austria), Austria

    2 publications · 140 citations

    2

    h-index

  2. AX
    April Xu

    Pfizer (United States), United States

    2 publications · 32 citations

    2

    h-index

  3. HP
    H. P. Schwarz

    Baxter (Austria), Austria

    2 publications · 140 citations

    2

    h-index

  4. GS
    Gerald Schrenk

    Baxter (Austria), Austria

    2 publications · 140 citations

    2

    h-index

  5. WH
    Werner Höllriegl

    Baxter (Austria), Austria

    2 publications · 140 citations

    2

    h-index

1–5 of 183

Institutions

57

  1. Pfizer (United States)

    New York, United States

    4 h-index

    23 publications

    426 citations

  2. Baxter (Austria)

    Vienna, Austria

    2 h-index

    17 publications

    800 citations

  3. University of Lisbon

    Lisbon, Portugal

    2 h-index

    3 publications

    193 citations

  4. University of Michigan

    Ann Arbor, United States

    2 h-index

    4 publications

    117 citations

  5. Ajinomoto (United States)

    Itasca, United States

    2 h-index

    8 publications

    276 citations

  6. Sam Higginbottom Institute of Agriculture

    Allahabad, India

    1 h-index

    3 publications

    66 citations

  7. Instituto Superior Técnico

    Lisbon, Portugal

    1 h-index

    5 publications

    280 citations

  8. Beijing Technology and Business University

    Beijing, China

    1 h-index

    1 publications

    48 citations

1–8 of 57

Venues

  1. Organic Process Research & Development

    3 publications · 56 citations

    3

    h-index

  2. Organic & Biomolecular Chemistry

    3 publications · 149 citations

    3

    h-index

  3. Comptes Rendus Chimie

    1 publications · 23 citations

    1

    h-index

  4. PubMed

    Repository · 1 publications · 96 citations

    1

    h-index

  5. Russian Chemical Reviews

    1 publications · 17 citations

    1

    h-index

1–5